SAFETY OF COMBINED PIRFENIDONE AND NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

被引：1

作者：

Flaherty, K. R. ^{[1
]}

Fell, C. D. ^{[2
]}

Huggins, J. T. ^{[3
]}

Nunes, H. ^{[4
]}

Sussman, R. ^{[5
]}

Valenzuela, C. ^{[6
]}

Petzinger, U. ^{[7
]}

Stauffer, J. L. ^{[8
]}

Gilberg, F. ^{[9
]}

Bengus, M. ^{[9
]}

Wijsenbeek, M. ^{[10
]}

机构：

[1] Univ Michigan, Ann Arbor, MI USA

[2] Univ Calgary, Calgary, AB, Canada

[3] Med Univ South Carolina, Charleston, SC USA

[4] Hop Avicenne, Paris, France

[5] Atlantic Hlth Syst, Overlook Med Ctr, Summit, NJ USA

[6] Hosp Univ La Princesa, Inst Invest Princesa, Madrid, Spain

[7] Clinipace Accovion GmbH, Eschborn, Germany

[8] Genentech Inc, San Francisco, CA 94080 USA

[9] F Hoffman La Roche Ltd, Basel, Switzerland

[10] Erasmus Univ, Med Ctr, Rotterdam, Netherlands

来源：

关键词：

D O I：

10.1136/thoraxjnl-2017-210983.453

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

M31

引用

页码：A253 / A254

页数：2